Ligand profile
NIA
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_2069 — purE
Identifiers
Database identifiers and provenance.
- Ligand ID
NIA- PDB
2ate- UniProt (similar protein)
P0AG18- Target protein
- VK055_2069
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 203.4
- −1 ≤ LogP ≤ 5 -1.90
- MW ≤ 500 Da 340.2
- LogP ≤ 5 -1.90
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 203.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N)[N+](=O)[O-]c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N)[N+](=O)[O-]
InChI=1S/C8H13N4O9P/c9-6-7(12(15)16)10-2-11(6)8-5(14)4(13)3(21-8)1-20-22(17,18)19/h2-5,8,13-14H,1,9H2,(H2,17,18,19)/t3-,4-,5-,8-/m1/s1InChI=1S/C8H13N4O9P/c9-6-7(12(15)16)10-2-11(6)8-5(14)4(13)3(21-8)1-20-22(17,18)19/h2-5,8,13-14H,1,9H2,(H2,17,18,19)/t3-,4-,5-,8-/m1/s1
YVRCVGZPIYHJLU-AFCXAGJDSA-NYVRCVGZPIYHJLU-AFCXAGJDSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00731
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand NIA →
- PDB RCSB structure 2ate →
- UniProt UniProt P0AG18 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “NIA”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2069.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 23
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).